Amphetamine differentially modifies the expression of monoaminergic and GABAergic synaptic boutons and processes in lateral habenula, dorsal and ventral hippocampal formation

NeuroToxicology

Volumn 33, Issue 2, 2012, Pages 235-245

  Yin, Hsiang Shu ^a,b   Tien, Tai Wei ^b   Li, Litzu ^c   Yang, Yaw Hua ^a   Lai, Chuan Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

Addiction; Attention; Calcium binding protein; HPLC; Memory; Synapses; Transmitter synthesizing enzymes

Indexed keywords

4 AMINOBUTYRIC ACID; AMPHETAMINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; GLUTAMATE DECARBOXYLASE 67; GLUTAMIC ACID; NORADRENALIN; PARVALBUMIN; SEROTONIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CELL INTERACTION; CONTROLLED STUDY; DENTATE GYRUS; GABAERGIC SYSTEM; GRANULE CELL; HABENULA; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; LONG TERM EXPOSURE; MALE; MONOAMINERGIC SYSTEM; MOUSE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPSE;

AMPHETAMINE; ANIMALS; BIOGENIC MONOAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HABENULA; HIPPOCAMPUS; MALE; MICE; MICROSCOPY, IMMUNOELECTRON; NEURONS; PRESYNAPTIC TERMINALS; TIME FACTORS;

MUS;

EID: 84858006374     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2011.10.001     Document Type: Article

References (43)

1. A receptors mediate the changes produced by stress on GABA function and locomotor activity. Neurosci Lett 1994, 176:29-31.
2. Andres K.H., During M.V., Veh R.W. Subnuclear organization of the rat habenular complexes. J Comp Neurol 1999, 407:130-150.
3. Beninger R.J., Tuerkea K.J., Forsytha J.K., Gilesa A., Xuec L., Boegmanc R.J., et al. Neonatal ventral hippocampal lesions in male and female rats: effects on water maze, locomotor activity, plus-maze and prefrontal cortical GABA and glutamate release in adulthood. Behav Brain Res 2009, 202:198-209.
4. Braak E., Strotkamp B., Braak H. Parvalbumin-immunoreactive structures in the hippocampus of the human adult. Cell Tissue Res 1991, 264:33-48.
5. Brunell S.C., Spear L.P. Effects of acute ethanol or amphetamine administration on the acoustic startle response and prepulse inhibition in adolescent and adult rats. Psychopharmacology (Berl) 2006, 186:579-586.
6. Degoulet M., Rouillon C., Rostain J.-C., David H.N., Abraini J.H. Modulation by the dorsal, but not ventral, hippocampus of the expression of behavioural sensitization to amphetamine. Int J Neuropsychopharmacol 2008, 11:497-508.
7. Del Arco A., Castaneda T.R., Mora F. Amphetamine releases GABA in striatum of the freely moving rat: involvement of calcium and high affinity transporter mechanisms. Neuropharmacology 1998, 37:199-205.
8. Dipace C., Sung U., Binda F., Blakely R.D., Galli A. Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Mol Pharmacol 2007, 71:230-239.
9. Doherty M.D., Gratton A. Effects of medial prefrontal cortical injections of GABA receptor agonists and antagonists on the local and nucleus accumbens dopamine responses to stress. Synapse 1999, 32:288-300.
10. Ellison G. Continuous amphetamine and cocaine have similar neurotoxic effects in lateral habenular nucleus and fasciculus retroflexus. Brain Res 1992, 598:353-356.
11. Ellison G. Stimulant-induced psychosis, the dopamine theory of schizophrenia and the habenula. Brain Res Rev 1994, 19:223-239.
12. Fanselow M.S., Dong H.W. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron 2009, 65:7-19.
13. Featherby T., van den Buuse M., Lubman D.I., Lawrence A.J. Persistent downregulation of hippocampal CREB mRNA parallels a Y-maze deficit in adolescent rats following semi-chronic amphetamine administration. Br J Pharmacol 2008, 154:417-428.
14. Featherstone R.E., Kapur S., Fletcher P.J. The amphetamine-induced sensitized state as a model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1556-1571.
15. Gage F.H., Thompson R.G. Differential distribution of norepinephrine and serotonin along the dorsal-ventral axis of the hippocampal formation. Brain Res Bull 1980, 5:771-773.
16. Glausier J.R., Khan Z.U., Muly E.C. Dopamine D1 and D5 receptors are localized to discrete populations of interneurons in primate prefrontal cortex. Cereb Cortex 2009, 19:1820-1834.
17. 2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Mol Pharmacol 2004, 66:137-143.
18. Hikosaka O., Sesack S.R., Lecourtier L., Shepard P.D. Habenula: crossed between the basal ganglia and the limbic system. J Neurosci 2008, 28:11825-11829.
19. Hillman K.L., Lei S., Doze V.A., Porter J.E. Alpha-1 adrenergic receptor activation increases inhibitory tone in CA1 hippocamnpus. Epilepsy Res 2009, 84:97-109.
20. Hörtnagl H., Berger M.L., Sperk G., Pifl C. Regional heterogeneity in the distribution of neurotransmitter markers in the rat hippocampus. Neuroscience 1991, 45:261-272.
21. A receptor-mediated mechanism. J Neurosci 2007, 27:6923-6930.
22. Katsurabayashi S., Kubota H., Tokutomi N., Akaike N. A distinct distribution of functional presynaptic 5-HT receptor subtypes on GABAergic nerve terminals projecting to single hippocampal CA1 pyramidal neurons. Neuropharmacology 2003, 44:1022-1030.
23. Kuczenski R., Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 2001, 296:876-883.
24. Lecourtier L., Kelly P.H. A conduction hidden in the orchestra? Role of the habenular complex in monoamine transmission and cognition. Neurosci Biobehav Rev 2007, 31:658-672.
25. Lecourtier L., Neijt H.C., Kelly P.H. Habenula lesions cause impaired cognitive performance in rats: implications for schizophrenia. Eur J Neurosci 2004, 19:2551-2560.
26. Lezcano N., Bergson C. D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. J Neurophysiol 2002, 87:2167-2175.
27. Lindefors N., Hurd Y.L., O'Connor W.T., Brene S., Persson H., Ungerstedt U. Amphetamine regulation of acetylcholine and gamma-aminobutyric acid in nucleus accumbens. Neuroscience 1992, 48:439-448.
28. Lipska B.K., Lerman D.N., Khaing Z.Z., Weinberger D.R. The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat striatum. Eur J Neurosci 2003, 18:3097-3104.
29. Mohila C.A., Onn S.P. Increases in the density of parvalbumin-immunoreactive neurons in anterior cingulate cortex of amphetamine-withdrawn rats: evidence for corticotropin-releasing factor in sustained elevation. Cereb Cortex 2005, 15:262-274.
30. 2+ and short-term facilitation. J Neurosci 2007, 27:2261-2271.
31. Nusser Z., Roberts J.D., Baude A., Richards J.G., Sieghart W., Somogyi P. Immunocytochemical localization of the alpha 1 and beta 2/3 subunits of the GABAA receptor in relation to specific GABAergic synapses in the dentate gyrus. Eur J Neurosci 1995, 7:630-646.
32. Reynold E.S. The use of lead citrate a high pH as an electron opaque stain in electron microscopy. J Cell Biol 1963, 17:208-212.
33. Sandyk R. Pineal and habenula calcification in schizophrenia. Int J Neurosci 1992, 67:19-30.
34. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 1993, 33:639-677.
35. Verney C., Baulac M., Berger B., Alvarez C., Vigny A., Helle K.B. Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat. Neuroscience 1985, 14:1039-1052.
36. Vincent S.L., Khan Y., Benes F.M. Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse 1995, 19:112-120.
37. Wirtshafter D., Asin K.E., Pitzer M.R. Dopamine agonists and stress produce different patterns of Fos-like immunoreactivity in the lateral habenula. Brain Res 1994, 633:21-26.
38. Wood S.C., Anagnostaras S.G. Memory and psychostimulants: modulation of pavlovian fear conditioning by amphetamine in C57BL/6 mice. Psychopharmacology (Berl) 2009, 202:197-206.
39. Yin H.S., Chen K., Kalpana S., Shih J.C. Differential effects of chronic amphetamine and baclofen administration on cAMP levels and phosphorylation of CREB in distinct brain regions of wild type and monoamine oxidase B-deficient mice. Synapse 2006, 60:573-584.
40. Yin H.S., Cheng P.R., Chen C.S. Differential alterations in the relations among GABAergic, catecholaminergic and calcium binding protein expression in the olfactory bulb of amphetamine-administered mouse. Neurotoxicology 2009, 30:103-113.
41. Yin H.S., Tan H.W. Effects of amphetamine on serotoninergic and GABAergic expression of developing brain. Neurotoxicol Teratol 2007, 29:264-272.
42. Yu M.F., Chien C.L., Lee W.T., Yin H.S. Effects of acute amphetamine administration on AMPA-mediated synaptic activity and expression of AMPA receptor subunit 2 of brain neurons. J Mol Neurosci 2005, 25:171-181.
43. Yin H.S., Lai C.C., Tien T.W., Han S.K., Pu X.L. Differential changes in cerebellar transmitter content and expression of calcium binding proteins and transcription factors in mouse administered with amphetamine. Neurochem Int 2010, 57:288-296.